In their latest for Westlaw Today and Thomson Reuters, Alex Malyshev and Sarah Ganley analyze the legal and policy considerations of the Drug Enforcement Administration’s move to reschedule Cannabis to Schedule III of the Controlled Substances Act. Alex and Sarah take a look at the rescheduling process and the impact the DEA’s move may have in the short term.
